Impact of Vaccination against Covid-19 in Indigenous Populations in Brazil
DOI:
https://doi.org/10.21270/archi.v14i4.6573Keywords:
COVID-19, Indigenous Peoples, VaccinesAbstract
Brazil's indigenous population is divided into Special Indigenous Health Districts. Certain conditions, such as their way of life, can aggravate the spread of diseases in this population. Native peoples were a priority group for vaccination against Covid-19. The aim of this study was to analyze the impact of vaccination against Covid-19 in indigenous populations compared to the Brazilian population. This is an observational, ecological study, based on bibliographic research and documentary analysis of records available on digital platforms and databases. A bibliographic survey was carried out on immunization against Covid-19 in indigenous populations. The period analyzed was from December 2019 to February 2024. Cases and deaths from Covid-19 in the Brazilian population and indigenous peoples were assessed separately, for both sexes and all age groups. The Brazilian population had a higher rate of contamination and deaths. Immunization in the first dose was similar and in the second dose 77% in indigenous peoples and 83% in the general population. It can be concluded that, even with greater adherence to immunization, the Brazilian population had a higher number of deaths when compared to the indigenous population. However, there was a lack of data on the populations analyzed.
Downloads
References
1. Rabby MII. Current Drugs with Potential for Treatment of COVID-19: A Literature Review. J Pharm Pharm Sci. 2020;23(1):58-64.
2. Roustit M, Guilhaumou R, Molimard M, Drici MD, Laporte S, Montastruc JL; French Society of Pharmacology and Therapeutics (SFPT). Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. Therapie. 2020;75(4):363-370.
3. Silva LMVG, Lima BCS, Junqueira TLS. População indígena em tempos de pandemia: reflexões sobre saúde a partir da perspectiva decolonial. Saúde Soc. 2023;32(2):e220092pt, 2023.
4. Instituto Brasil de Geografia e Estatística - IBGE. Censo Demográfico 2022. 2023. Disponível em: https://censo2022.ibge.gov.br/ Acesso em: 16 ago. 2023.
5. BRASIL. Ministério da Saúde. Distrito Sanitário Especial Indígena. 2023a. Disponível em: https://www.gov.br/saude/pt-br/composicao/sesai/estrutura/dsei. Acesso em: 25 jan. 2023.
6. BRASIL. Ministério da Saúde. Investigação de surto de síndrome gripal em populações indígenas, Altamira-Pará, abril-setembro de 2010. Boletim Epidemiológico da Secretaria de Vigilância em Saúde, v. 43, n. 3, p. 11-16. 2012. Disponível em: https://bvsms.saude.gov.br/bvs/periodicos/boletim_epidemiologico_numero_3.pdf. Acesso em: 6 fev. 2023.
7. Cardoso AM, Horta BL, Santos RV, Escobar AL, Welch JR, Coimbra CE Jr. Prevalence of pneumonia and associated factors among indigenous children in Brazil: results from the First National Survey of Indigenous People's Health and Nutrition. Int Health. 2015;7(6):412-9.
8. Guaratira SSC, Costa CDN. Experiences of Sakurabiat Language and Culture Rescue. Cad. Linguíst. 2020;(3):1-14.
9. Marinelli NP, Nascimento DF, Costa AIP, Posso MBS, Araújo LP. Assistência à população indígena: dificuldades encontradas por enfermeiros. Rev Univap 2012, 18(32):52-65.
10. Malacarne J, Gava C, Escobar AL, Souza-Santos R, Basta PC. Health service access for tuberculosis diagnosis and treatment among indigenous peoples in Rondônia state, Brazilian Amazon, 2009-2011: a cross-sectional study. Epidemiol Serv Saude. 2019;28(3):e2018231.
11. Rodrigues FI, Garbin CAS, Moimaz SAS, Saliba NA. Análise documental dos serviços de saúde bucal ofertados à população indígena no Brasil. Rev Ciênc Plural. 2018;4(1):7-21.
12. Cristaldo HC, Brandão M. Vacinação contra a covid-19 começa em todo o país. 2021. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2021-01/vacinacao-contra-covid-19-come%C3%A7a-em-todo-o-pais. Acesso em: 17 out. 2023.
13. Chaney D, Lee MS. COVID-19 vaccines and anti-consumption: Understanding anti-vaxxers hesitancy. Psychol Mark. 2022;39(4):741-754.
14. Silva S, Araújo DS, Ribeiro F, Araújo CS. Vacinar ou arriscar? A mensagem da Organização Mundial de Saúde para promover a vacinação contra a covid-19. Saúde Soc.2024;33(1): e220584.
15. Cerqueira-Silva T, Katikireddi SV, de Araujo Oliveira V, Flores-Ortiz R, Júnior JB et al. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nat Med. 2022;28(4):838-843.
16. Rosenblum HG, Gee J, Liu R, Marquez PL, Zhang B, Strid P,et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis. 2022;22(6):802-812.
17. Barbosa FB, Sagica FES, Jesus MI, Moraes MM. Soroprevalência de anticorpos contra o sarampo na cidade de Belém, Pará, Brasil (2016 – 2018) e a reintrodução do vírus em 2018. REASE. 2023; 9:2353-65.
18. Pereira JPC, Braga GM, Costa GA. Negligência à vacinação: o retorno do sarampo ao Brasil. e-Scientia. 2019;12(1):1-5.
19. Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS One. 2021;16(8):e0254347.
20. Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021;174(4):576-578.
21. Queiroz BL. Challenges related to records and quality of information in the Amazon. Cad Saude Publica. 2023;39(7):e00098323.
22. BRASIL. Ministério da Saúde. Vacinômetro. 2023b. Disponível em: https://infoms.saude.gov.br/extensions/SEIDIGI_DEMAS_Vacina_C19/SEIDIGI_DEMAS_Vacina_C19.html. Acesso em: 6 fev. 2023.
23. BRASIL. Ministério da Saúde. Painel Coronavírus. 2023c. Disponível em https://covid.saude.gov.br/. Acesso em: 6 fev. 2023.
24. BRASIL. Ministério da Saúde. Boletim Epidemiológico da SESAI. 2022. Disponível em: http://www.saudeindigena.net.br/coronavirus/mapaEp.php. Acesso em: 16 ago. 2023.
25. Dias GZT, Moimaz SAS, Oliveira JMA, Saliba TA. Saúde Indígena: Análises do Impacto da Presença da Casa de Saúde Indígena (CASAI) nos Distritos Sanitários Especiais Indígenas (DSEI) durante a Pandemia de COVID- 19. Arch health Invest. 2023;12(10):1969–74.
26. Araújo GM, Silva DCG, Carneiro TA, Neves WC, Barbosa JSP. A importância da vacinação como promoção e prevenção de doenças: uma revisão integrativa. REAEnf. 2022;19:e10547.
27. Oliveira JMA, Moimaz SAS, Saliba TA, Garbin AJI. Os povos indígenas e a Covid-19 nos Distritos Sanitários Especiais Indígenas (DSEI) de Mato Grosso: Um estudo ecológico. Res Soc Dev. 2021;10(1):e46510111178.
28. Martins TM. Coronavírus: orientações para povos indígenas. 2020. Disponível em: https://ascom.ufpa.br/links/outros/COVID_CARTILHA_DSEI_UFPA%20%281%29.pdf. Acesso em: 3 jul. 2023.
29. Ferreira VP, Christofoletti R. COVID-19 e combate à desinformação: a experiência do Consórcio de Veículos de Imprensa no Brasil. Cuadernos info. 2024;(57):137-157.
30. Oliveira AMC, Dantas ACMTV, Souza AA, Marinho RA, Martins ALJ, Paes-Sousa R. População em situação de rua: comunicação e (des)informação no contexto da pandemia de Covid-19. Interface (Botucatu). 2024;28:e230433.
